Cargando…
The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction()
PURPOSE: To inveatigate how effective LMWH was at preventing venous thromboembolism (VTE), major bleeding events, and minor bleeding events after simple knee arthroscopic surgery and anterior cruciate ligament reconstruction (ACLR). METHODS: We conducted a comprehensive search of PubMed, EMBASE, Coc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558934/ https://www.ncbi.nlm.nih.gov/pubmed/37810025 http://dx.doi.org/10.1016/j.heliyon.2023.e19696 |
_version_ | 1785117393324867584 |
---|---|
author | Li, Hui-Min Huang, Leyi Fu, Junwei Tong, Zhicheng Wei, Wei Teng, Chong |
author_facet | Li, Hui-Min Huang, Leyi Fu, Junwei Tong, Zhicheng Wei, Wei Teng, Chong |
author_sort | Li, Hui-Min |
collection | PubMed |
description | PURPOSE: To inveatigate how effective LMWH was at preventing venous thromboembolism (VTE), major bleeding events, and minor bleeding events after simple knee arthroscopic surgery and anterior cruciate ligament reconstruction (ACLR). METHODS: We conducted a comprehensive search of PubMed, EMBASE, Cochrane Library, and the CNKI database for potentially eligible articles. The outcomes were evaluated in terms of odds ratio (OR) and the associated 95% confidence intervals (CIs). Meta-analysis was performed using the Stata software and subgroup analyses were performed based on the surgical setting including ACLR and simple knee arthroscopic surgery. RESULTS: A total of eight studies with 2249 patients and 1794 controls were included in this meta-analysis. In patients undergoing simple knee arthroscopic surgery, LMWH prophylaxis did not bring a significant reduction in the risk of symptomatic deep venous thrombosis (DVT), symptomatic pulmonary embolism (PE), symptomatic VTE, and did not increase the risk of major bleeding events, but did have a higher risk of minor bleeding events (OR = 1.95, 95% CI 1.34–2.84, P = 0.000) and a lower risk of asymptomatic DVT (OR = 0.14, 95% CI 0.04–0.53, P = 0.004) in comparison with non-LMWH prophylaxis. In patients undergoing ACLR, LMWH prophylaxis did not bring a significant reduction in the risk of symptomatic DVT, symptomatic PE, symptomatic VTE, and did not increase the risk of major bleeding events and minor bleeding events, but did have a lower risk of asymptomatic DVT (OR = 0.43, 95% CI 0.23–0.78, P = 0.006). CONCLUSION: When compared to a control group, this meta-analysis found that LMWH had little potential benefit in preventing major VTE (symptomatic VTE, symptomatic DVT, and symptomatic PE) after simple knee arthroscopy and ACLR. As a result, LMWH should not be considered routinely in patients undergoing knee arthroscopic surgery. |
format | Online Article Text |
id | pubmed-10558934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105589342023-10-08 The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() Li, Hui-Min Huang, Leyi Fu, Junwei Tong, Zhicheng Wei, Wei Teng, Chong Heliyon Research Article PURPOSE: To inveatigate how effective LMWH was at preventing venous thromboembolism (VTE), major bleeding events, and minor bleeding events after simple knee arthroscopic surgery and anterior cruciate ligament reconstruction (ACLR). METHODS: We conducted a comprehensive search of PubMed, EMBASE, Cochrane Library, and the CNKI database for potentially eligible articles. The outcomes were evaluated in terms of odds ratio (OR) and the associated 95% confidence intervals (CIs). Meta-analysis was performed using the Stata software and subgroup analyses were performed based on the surgical setting including ACLR and simple knee arthroscopic surgery. RESULTS: A total of eight studies with 2249 patients and 1794 controls were included in this meta-analysis. In patients undergoing simple knee arthroscopic surgery, LMWH prophylaxis did not bring a significant reduction in the risk of symptomatic deep venous thrombosis (DVT), symptomatic pulmonary embolism (PE), symptomatic VTE, and did not increase the risk of major bleeding events, but did have a higher risk of minor bleeding events (OR = 1.95, 95% CI 1.34–2.84, P = 0.000) and a lower risk of asymptomatic DVT (OR = 0.14, 95% CI 0.04–0.53, P = 0.004) in comparison with non-LMWH prophylaxis. In patients undergoing ACLR, LMWH prophylaxis did not bring a significant reduction in the risk of symptomatic DVT, symptomatic PE, symptomatic VTE, and did not increase the risk of major bleeding events and minor bleeding events, but did have a lower risk of asymptomatic DVT (OR = 0.43, 95% CI 0.23–0.78, P = 0.006). CONCLUSION: When compared to a control group, this meta-analysis found that LMWH had little potential benefit in preventing major VTE (symptomatic VTE, symptomatic DVT, and symptomatic PE) after simple knee arthroscopy and ACLR. As a result, LMWH should not be considered routinely in patients undergoing knee arthroscopic surgery. Elsevier 2023-09-06 /pmc/articles/PMC10558934/ /pubmed/37810025 http://dx.doi.org/10.1016/j.heliyon.2023.e19696 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Li, Hui-Min Huang, Leyi Fu, Junwei Tong, Zhicheng Wei, Wei Teng, Chong The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title | The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title_full | The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title_fullStr | The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title_full_unstemmed | The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title_short | The efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
title_sort | efficacy and safety of low-molecular-weight heparin in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction() |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558934/ https://www.ncbi.nlm.nih.gov/pubmed/37810025 http://dx.doi.org/10.1016/j.heliyon.2023.e19696 |
work_keys_str_mv | AT lihuimin theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT huangleyi theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT fujunwei theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT tongzhicheng theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT weiwei theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT tengchong theefficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT lihuimin efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT huangleyi efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT fujunwei efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT tongzhicheng efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT weiwei efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction AT tengchong efficacyandsafetyoflowmolecularweightheparininpatientsundergoingkneearthroscopicsurgeryandanteriorcruciateligamentreconstruction |